Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CANC

Tema Oncology ETF

Nov 07 • 04:00PM ET

30.68

-0.28 -0.89 %

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	10.16%	Total Holdings	54	Perf Week	-0.97%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	86.91M	Perf Month	2.33%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	20.98%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	31.55 -2.76%	Perf Half Y	31.95%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	20.10 52.67%	Perf YTD	26.21%
Active/Passive		Quant Type		Tags	-	Flows% 1M	0.72%	Volatility	1.73% 1.58%	Perf Year	9.87%
Dividend TTM	0.50 (1.63%)	ESG Type		Tags	-	Flows% 3M	5.96%	ATR (14)	0.52	Perf 3Y	-
Dividend Ex-Date	Dec 11, 2024	Dividend Type		Sector/Theme		Flows% YTD	33.47%	RSI (14)	59.61	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	1.01	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	1.00%	Flows% 3Y		Rel Volume	0.97	Prev Close	30.96
Inverse/Leveraged		Market Cap		SMA50	6.09%	Flows% 5Y		Avg Volume	9.16K	Price	30.68
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	18.08%	Trades		Volume	8,903	Change	-0.89%

Oct-20-25 06:00AM

Biotech ETFs Bounce Back in 2025: Here's Why

(Zacks)

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience